Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-24-113150
Filing Date
2024-12-27
Accepted
2024-12-27 17:00:41
Documents
55
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ea0225372-10k_citius.htm   iXBRL 10-K 875041
2 DESCRIPTION OF COMMON STOCK ea022537201ex4-2_citius.htm EX-4.2 28097
3 2023 OMNIBUS STOCK INCENTIVE PLAN ea022537201ex10-3_citius.htm EX-10.3 140949
4 INSIDER TRADING POLICY ea022537201ex19-1_citius.htm EX-19.1 62630
5 CERTIFICATION ea022537201ex31-1_citius.htm EX-31.1 9679
6 CERTIFICATION ea022537201ex31-2_citius.htm EX-31.2 9796
7 CERTIFICATION ea022537201ex32-1_citius.htm EX-32.1 4134
  Complete submission text file 0001213900-24-113150.txt   3901304

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE tenk-20240930.xsd EX-101.SCH 29035
9 XBRL CALCULATION FILE tenk-20240930_cal.xml EX-101.CAL 21955
10 XBRL DEFINITION FILE tenk-20240930_def.xml EX-101.DEF 145960
11 XBRL LABEL FILE tenk-20240930_lab.xml EX-101.LAB 284429
12 XBRL PRESENTATION FILE tenk-20240930_pre.xml EX-101.PRE 157005
57 EXTRACTED XBRL INSTANCE DOCUMENT ea0225372-10k_citius_htm.xml XML 220428
Mailing Address 420 LEXINGTON AVE, SUITE 2446 NEW YORK NY 10017
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6677
CITIUS ONCOLOGY, INC. (Filer) CIK: 0001851484 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 001-41534 | Film No.: 241586208
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)